From: Survival and success of implants in a private periodontal practice: a 10 year retrospective study
a | |||||
Total | XiVE | Frialit-2 Synchro | Implant lost | Implant in situ | |
Baseline data | n = 242 | n = 212 | n = 30 | n = 9 | n = 233 |
Implanttyp | |||||
XIVE S Cellplus | 212 (87.6%) | 2 (0.9%) | 210 (99.1%) | ||
Frialit-2-Synchro | 30 (12.4%) | 7 (23.3%) | 23 (76.7%) | ||
Implant diametre | |||||
3 mm | 3 (1.3%) | 3 (100%) | 0 (0%) | 0 (0%) | 3 (100%) |
3.4 mm | 28 (11.6%) | 24 (85.7%) | 4 (14.3%) | 4 (14.3%) | 24 (85.7%) |
3.8 mm | 111 (45.9%) | 94 (84.7%) | 17 (15.3%) | 2 (1.8%) | 109 (98.2%) |
4.5 mm | 88 (36.4%) | 80 (90.9%) | 8 (9.1%) | 2 (2.3%) | 86 (97.7%) |
5.5 mm | 12 (5.0%) | 11 (91.7%) | 1 (8.3%) | 1 (8.3%) | 11 (91.7%) |
Implant lenght | |||||
8 mm | 2 (0.8%) | 2 (100%) | 0 (0%) | 0 (0%) | 2 (100%) |
9.5 mm | 10 (4.1%) | 10 (100%) | 0 (0%) | 1 (10.0%) | 9 (90.0%) |
10 mm | 6 (2.5%) | 0 (0%) | 6 (100%) | 2 (33.3%) | 4 (66.7%) |
11 mm | 40 (16.5%) | 39 (97.5%) | 1 (2.5%) | 0 (0%) | 40 (100%) |
13 mm | 138 (57.0%) | 122 (88.4%) | 16 (11.6%) | 1 (0.7%) | 137 (99.3%) |
15 mm | 46 (19.0%) | 39 (84.8%) | 7 (15.2%) | 5 (10.9%) | 41 (89.1%) |
Implant position (Jaw) | |||||
Maxilla | 136 (56.2%) | 121 (89.0%) | 15 (11.0%) | 1 (0.7%) | 135 (99.3%) |
Mandible | 106 (43.8%) | 91 (85.9%) | 15 (14.1%) | 8 (7.5%) | 98 (92.5%) |
Implant Position | |||||
Anterior | 56 (23.1%) | 42 (75.0%) | 14 (25.0%) | 6 (10.7%) | 50 (89.3%) |
Posterior | 186 (76.9%) | 170 (91.4%) | 16 (8.6%) | 3 (1.6%) | 183 (98.4%) |
Time of Implant placement | |||||
time of tooth extraction not known | 21 (8.7%) | 17 (81.0%) | 4 (19.0%) | 0 (0%) | 21 (100%) |
immediate implant | 23 (9.5%) | 18 (78.3%) | 5 (21.7%) | 4 (17.4%) | 19 (82.6%) |
delayed immediate implant | 1 (0.4%) | 1 (100%) | 0 (0%) | 0 (0%) | 1 (100%) |
6–12-weeks afer extraction | 18 (7.4%) | 15 (83.3%) | 3 (16.7%) | 2 (11.1%) | 16 (88.9%) |
> 12 weeks to < 6 months | 22 (9.1%) | 19 (86.4%) | 3 (13.6%) | 0 (0%) | 22 (100%) |
≥ 6 Monate | 157 (64.9%) | 142 (90.5%) | 15 (9.5%) | 3 (1.9%) | 154 (98.1%) |
Augmentation | |||||
none | 51 (21.1%) | 45 (88.2%) | 6 (11.8%) | 1 (2.0%) | 50 (98.0%) |
internal sinus lift | 9 (3.7%) | 9 (100%) | 0 (0%) | 0 (0%) | 9 (100%) |
external sinus lift | 54 (22.4%) | 50 (92.6%) | 4 (7.4%) | 0 (0%) | 54 (100%) |
bone substitute/membran | 111 (45.9%) | 97 (87.4%) | 14 (12.6%) | 4 (3.6%) | 107 (96.4%) |
block augmentation | 9 (3.7%) | 8 (88.9%) | 1 (11.1%) | 0 (0%) | 9 (100%) |
soft tissue | 3 (1.3%) | 2 (66.7%) | 1 (33.3%) | 0 (0%) | 3 (100%) |
distraction osteogeneses | 5 (2.1%) | 1 (20.0%) | 4 (80.0%) | 4 (80.0%) | 1 (20.0%) |
Implant healing (n = 234) | |||||
submerged | 176 (75.2%) | 153 (86.9%) | 23 (13.1%) | 1 (0.6%) | 175 (99.4%) |
non-submerged | 58 (24.8%) | 57 (98.3%) | 1 (1.7%) | 8 (13.8%) | 50 (86.2%) |
Connection implant/suprastructure | |||||
cemented | 227 (93.8%) | 210 (92.5%) | 17 (7.5%) | 0 (0%) | 227 (100%) |
screwed | 6 (2.5%) | 0 (0%) | 6 (100%) | 1 (16.7%) | 5 (93.3%) |
b | |||||
Reexamination data | Total n = 233 | ||||
PPD (mean per implant) | 3.16 mm ± 1.02 (range 1.00–8.00 mm) | ||||
Bone loss (maximum per implant) | 0.78 mm ± 1.41 (range 0.00–6.10 mm) | ||||
< 1 mm | 63.3% of all implants | ||||
1 mm - < 2 mm | 16.5% | ||||
2 mm - < 3 mm | 9.4% | ||||
3 mm - < 4 mm | 4.7% | ||||
≥ 4 mm | 6.1% | ||||
BOP (at least one positive site per implant) | |||||
positive | 202 (86.7%) | ||||
negative | 31 (13.3%) | ||||
Width of keratinized gingiva | |||||
0 mm | 31 (13.3%) | ||||
0.5 mm | 1 (0.4%) | ||||
1.0 mm | 32 (13.7%) | ||||
1.5 mm | 1 (0.4%) | ||||
2.0 mm | 70 (30.0%) | ||||
3.0 mm | 48 (20.6%) | ||||
3.5 mm | 1 (0.4%) | ||||
4.0 mm | 27 (11.6%) | ||||
5.0 mm | 13 (5.6%) | ||||
6.0 mm | 9 (3.9%) | ||||
mod. GI (maximum per implant) according to Mombelli et al. (1987) | |||||
0 | 130 (55.8%) | ||||
1 | 62 (26.6%) | ||||
2 | 32 (13.7%) | ||||
3 | 9 (3.9%) | ||||
mod. PI (maximum per implant) | |||||
0 | 54 (23.2%) | ||||
1 | 71 (30.5%) | ||||
2 | 85 (36.5%) | ||||
3 | 23 (9.9%) |